HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dinesh Rakheja Selected Research

Acute fatty liver of pregnancy

1/2008Highly active antiretroviral therapy does not affect mitochondrial beta-oxidation of fatty acids: an in vitro study in fibroblasts.
6/2003Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases.
7/2002Long-chain L-3-hydroxyacyl-coenzyme a dehydrogenase deficiency: a molecular and biochemical review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dinesh Rakheja Research Topics

Disease

56Neoplasms (Cancer)
09/2022 - 02/2003
8Renal Cell Carcinoma (Grawitz Tumor)
07/2021 - 11/2005
7Wilms Tumor (Wilm's Tumor)
01/2020 - 06/2012
5Carcinogenesis
01/2020 - 06/2005
4Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2022 - 12/2009
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 10/2012
4Glioma (Gliomas)
02/2015 - 03/2011
4Neoplasm Metastasis (Metastasis)
10/2012 - 12/2006
3Endodermal Sinus Tumor (Endodermal Sinus Tumors)
01/2018 - 10/2009
3Hepatoblastoma
10/2016 - 12/2009
3Carcinoma (Carcinomatosis)
07/2011 - 08/2005
3Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
03/2008 - 05/2004
3Acute fatty liver of pregnancy
01/2008 - 07/2002
3Pre-Eclampsia (Preeclampsia)
01/2008 - 07/2002
3Hemolysis
01/2008 - 07/2002
2Adenocarcinoma
01/2022 - 01/2005
2Kidney Neoplasms (Kidney Cancer)
11/2020 - 11/2014
2Rhabdomyosarcoma
01/2020 - 01/2018
2Osteosarcoma (Osteogenic Sarcoma)
01/2019 - 01/2017
2Embryonal Carcinoma
01/2018 - 04/2002
2Inflammation (Inflammations)
10/2016 - 09/2011
2Brain Neoplasms (Brain Tumor)
10/2015 - 10/2012
2Hypoxia (Hypoxemia)
06/2014 - 06/2013
2Glomerulonephritis
02/2013 - 09/2011
2Glioblastoma (Glioblastoma Multiforme)
01/2013 - 10/2012
2Chronic Renal Insufficiency
06/2012 - 01/2011
2Ewing Sarcoma (Sarcoma, Ewing)
01/2012 - 12/2010
2Aggressive Fibromatosis (Desmoid)
11/2008 - 06/2005
2Fibroma (Fibromatosis)
11/2008 - 06/2005
2Smith-Lemli-Opitz Syndrome
03/2008 - 08/2004
2Neuroblastoma
11/2006 - 06/2006
1Sarcoma (Soft Tissue Sarcoma)
06/2022
1Acinar Cell Carcinoma
01/2022
1COVID-19
10/2021
1renal Oncocytoma
07/2021
1Myofibromatosis
10/2019
1Necrosis
01/2019
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
08/2018
1Choriocarcinoma
01/2018
1Pleomorphic Adenoma
01/2018

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
09/2022 - 02/2003
9alpha-hydroxyglutarateIBA
01/2017 - 03/2011
7Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2018 - 03/2011
6EnzymesIBA
11/2020 - 07/2002
5alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022 - 10/2009
5Biomarkers (Surrogate Marker)IBA
12/2017 - 01/2015
4Transcription Factors (Transcription Factor)IBA
11/2020 - 01/2012
4DNA (Deoxyribonucleic Acid)IBA
10/2019 - 07/2012
4Oxidoreductases (Dehydrogenase)IBA
12/2018 - 01/2008
4ErbB Receptors (EGF Receptor)IBA
01/2018 - 04/2009
4Fatty Acids (Saturated Fatty Acids)IBA
01/2017 - 06/2003
4Mucin-1 (CA 15-3 Antigen)IBA
10/2009 - 02/2003
3Keratin-7 (Cytokeratin 7)IBA
01/2022 - 04/2002
3Biological ProductsIBA
01/2022 - 01/2005
3Oncogene Proteins (Oncogene Protein)IBA
01/2021 - 01/2012
3CollagenIBA
01/2021 - 02/2003
3Glucose (Dextrose)FDA LinkGeneric
11/2020 - 07/2012
3MicroRNAs (MicroRNA)IBA
01/2018 - 09/2014
3isocitric acid (isocitrate)IBA
01/2015 - 03/2011
3Histones (Histone)IBA
11/2014 - 01/2007
3Codon (Codons)IBA
08/2012 - 03/2011
3beta CateninIBA
12/2009 - 06/2005
3Fatty Acid Synthases (Fatty Acid Synthase)IBA
01/2007 - 01/2005
2Phosphotransferases (Kinase)IBA
01/2021 - 01/2013
2Messenger RNA (mRNA)IBA
11/2020 - 01/2020
2CateninsIBA
01/2020 - 10/2016
25-hydroxymethylcytosineIBA
01/2019 - 11/2014
2Mechanistic Target of Rapamycin Complex 1IBA
01/2018 - 01/2018
2AcidsIBA
01/2017 - 09/2010
2Citric Acid (Citrate)FDA LinkGeneric
01/2017 - 06/2014
2Lactic Acid (Lactate)FDA LinkGeneric
01/2017 - 10/2012
2Hormones (Hormone)IBA
10/2015 - 01/2013
2NADP (NADPH)IBA
06/2014 - 03/2011
2TeaIBA
05/2014 - 09/2011
2Protein Isoforms (Isoforms)IBA
10/2012 - 09/2011
2LigandsIBA
09/2011 - 03/2007
2Caspase 3 (Caspase-3)IBA
12/2010 - 01/2007
2GlypicansIBA
12/2009 - 10/2009
2CholesterolIBA
03/2008 - 08/2004
2Membrane LipidsIBA
03/2008 - 05/2004
2Detergents (Detergent)IBA
03/2008 - 05/2004
2LipidsIBA
03/2008 - 01/2005
2Keratins (Keratin)IBA
05/2006 - 03/2005
2AntibodiesIBA
05/2006 - 06/2005
1Tyrosine Kinase InhibitorsIBA
09/2022
1CrizotinibIBA
09/2022
1EpitopesIBA
06/2022
1tyrosine receptor (receptor, tyrosine)IBA
01/2021
1IsotopesIBA
11/2020
1BMS 754807IBA
01/2020
1Complementary DNA (cDNA)IBA
10/2019
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
10/2019
1Imatinib Mesylate (Gleevec)FDA Link
10/2019
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
01/2019
1CytosineIBA
01/2019
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
08/2018

Therapy/Procedure

9Therapeutics
01/2022 - 03/2007
6Drug Therapy (Chemotherapy)
01/2019 - 12/2010
3Nephrectomy
10/2012 - 06/2012
1Personal Protective Equipment
10/2021